Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the Efficacy and Safety of Hyaluronic Acid (Restylane®) for the Treatment of Tear Trough Deformity

NCT04486794 is registered in ClinicalTrials.gov with Erevna Innovations Inc. as lead sponsor.

NCT NCT04486794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the Efficacy and Safety of Hyaluronic Acid (Restylane®) for the Treatment of Tear Trough Deformity
Lead sponsor
Erevna Innovations Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 7, 2019
Completion date
December 31, 2020
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tear trough eyelid deformity